Biostar Pharmaceuticals Net Tangible Assets

Biostar Pharmaceuticals (BSPM) currently reports a net tangible assets of $36M as of September 2017. That compares with $34M in the prior-year period — up 6.2% year over year. Use the charts on this page to explore Biostar Pharmaceuticals's net tangible assets history and peer comparisons.

Biostar Pharmaceuticals's net tangible assets increased from $34M to $36M — a 6.2% year-over-year increase (period ending September 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biostar Pharmaceuticals reported $36M in net tangible assets as of September 2017. That compares with $34M in the prior-year period — up 6.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biostar Pharmaceuticals, and consider following BSPM for alerts when major investors trade the stock.